Bactivec

BACTIVEC® is produced by a Labiofam, a company from Cuba. It is produced in aqueous formulas containing spores and protein crystals of Bacillus thuringiensis, var israelensis, serotype H-14, strain 266/2. It also contains more than 1200 ITU / mg, which is an index toxicity unit to kill mosquito larvae. The control of mosquito bacteria has been used worldwide for over 30 years, the Bio-larvicide effectively controls the vector of many human diseases, including Dengue, Malaria and Encephalitis. Since 1970, WHO has recommended the establishment of biological methods in all vector control measures to be implemented for Malaria and other Disease Control Programs (WHO Resolution 23, 33, 1, 1970). WHO recommends microbial insecticides: Bacillus thuringiensis, var. israelensis (Bti-SH14). BACTIVEC® was registered in Malaysia with Pesticide Board, Ministry of Agriculture and Agro-based Industry Malaysia issued license number LRMP.R1 / 10028 under RCS Agri Supplies Sdn. Bhd., on February 1, 2019. 

APPLICATIONS:

Directly used from the packaging drum. No dilution needed neither water mixing. 

Dosage of 5 ml per 1 meter square area - sporadic spraying to target spot such as drains, roofing gutters, pots plant that contain water and all plants that able to trap rain water.

50 litres for 1 hectare area as blanket spraying - e.g. swampy are and river banks.

Equipment; normal knapsack sprayer, or hand-held sprayer or mist blower. - using mist blower is much efficient (dispensing liquid in ultra-low volume, ULV). 

MODE OF ACTION

1. When the larvae consume BACTIVEC®, the crystal protein toxin is released and upon entry into the acidic digestive system,
2. The active crystal protein toxin attacks the stomach cells and causes the stomach to flutter.
3. It comes out of the digestive system and causes the larvae to die after being infected with BTi within a few days.
4. Although the larvae do not die quickly when attacked but within a few hours it is weak, inactive and in some cases the larvae stop eating.
5. This BTi serotype H-14, strain 266/2 susceptibility is specific to only mosquito larvae such as Aedes sp., Anopheles sp., and Culex sp.
6. This serotype H-14, 266/2 does not cause any effect on other organism

ADVANTAGES

1. One application kills Mosquito larvae in stages I-III and the beginning of stage IV through ingestion.
2. It does not lead to resistance.
3. It is effective in all cases, including mosquito populations resistant to chemical products. 
4. No side effect and does not harm human or domestic animals.
5. Biodegradable - does not harm the environment.
6. It produces rapid results (within 24 hours) and affects a great number of mosquito species including the carriers of Dengue. It is very suitable for small breeding areas (less than one hectare) such as housing area, construction site, workers settlement/hostel in plantation and can be used in emergency epidemiological situations, knock out phase for controlling mosquito borne diseases such as dengue. Effective control is maintained by applications every 30 days outside and inside mosquito breeding areas.